Daniel Faga

Dan has more than 20 years of operating and advisory experience in the life sciences industry. He has served as Anaptys’ president and chief executive officer since March 2022. Previously, he was chief operating officer at Mirati Therapeutics responsible for leading the company’s corporate strategy, finance, legal and other business operations. Prior to Mirati, Dan was chief business officer at Spark Therapeutics until its acquisition by Roche. Previously, Dan was a managing director and founding member of Centerview Partner’s healthcare advisory practice. Dan’s earlier experience includes healthcare investment banking at Merrill Lynch and management consulting in the life sciences practice at PRTM.

Dan earned a B.S. in engineering from Cornell University and an MBA in healthcare management from the Wharton School of the University of Pennsylvania.